Cedars-Sinai Accelerator: A Powerhouse in Healthcare Innovation Attracting 600 Startups Per Cohort

The United States is the country with the most advanced healthcare system globally and also has the largest number of top-tier medical centers. On the latest global ranking of healthcare institutions,Twenty-two U.S. medical institutions are ranked among the top 100., with four medical institutions ranking among the top five, namelyMayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and Johns Hopkins Hospital.

In fact, these top-tier medical centers not only possess formidable clinical strength but have also achieved significant success in medical innovation and translation, effectively serving as the cornerstone of the United States’ leadership in the field of medical innovation.

According to the latest data,Mayo ClinicTo date, 140,000 medical innovation achievements have been successfully incubated, with an additional 12,000 innovative technologies currently in the research and translation stages;Cleveland ClinicIn 2021, 92 innovative projects were successfully commercialized, attracting over $1.3 billion in investment;Johns Hopkins HospitalIn 2021, a total of 166 new patents were granted, and the number of incubated startups reached 174;Massachusetts General Hospital was granted 484 patents in 2021, with research income reaching $142.9 million.

But this is just the “tip of the iceberg”, located in Los AngelesCedars-Sinai Medical CenterIt also demonstrates strong performance in innovation and translation.

It is reported that this non-profit hospital, the largest on the U.S. West Coast and founded in 1902, currently employs more than 2,000 physicians and 10,000 staff members to meet the needs of one of the most diverse regions in the nation. It has set rigorous standards in quality and innovative patient care, research, teaching, and community service, providing an excellent environment for supporting medical innovation.

To accelerate the translation of in-hospital medical innovations and enable faster application of cutting-edge technologies in hospitals and for patients,Cedars-Sinai Medical CenterEstablished an accelerator, namelyCedars-Sinai Accelerator, it is a key engine for medical development established with the support of TechStars, a professional incubator. The incubator primarily provides training and mentorship to healthcare innovation startups, fostering their growth and innovation to accelerate company development.

So, what kind of boost can Cedars-Sinai Accelerator actually provide to startups? And how does it balance the risks and opportunities in incubating early-stage medical projects? To unravel this mystery, VCBeat’s Orange Bureau conducted an in-depth analysis of the incubator.

From its startup and seed stages to its rapid growth phase, the company has correspondinglyPhysical Space, Supporting Facilities, Technology Platforms, Investment and Financing, Market Networks, Human ResourcesThese evolving conditions have raised higher demands. The existence of accelerators is precisely to help startups fill these gaps.

As an accelerator widely favored by U.S. startups, the Cedars-Sinai Accelerator primarily offers startupsFunding. It is reported that each startup joining Cedars-Sinai will receive$100,000。

But this is not the most important aspect; the true value of Cedars-Sinai lies in itsDeveloped a Detailed Funding Plan Network for Startups. Within this program network, financial investment constitutes only a small fraction; the core value of Cedars-Sinai lies in calibrating financing pacing based on startups’ actual circumstances and precisely matching them with the most suitable investment institutions.

To some extent, this is far more important than money, especially for startups, which often need to secure more market resources in their early stages rather than just “money.” Because if they only have “money,” it may burden them with unnecessary pressure.

After completing the funding plan, the second step for Cedars-Sinai Accelerator is to assist startups“Investing” Time. Resources are finite, and so is time; therefore, Cedars-Sinai consistently selects high-quality enterprises that deliver truly valuable solutions to the healthcare industry, dedicating the time and energy of stakeholders across its entire health system to these partnerships.

At this juncture, the value that Cedars-Sinai can bring is more about providing startups withProject Coachingand in vertical sectorsMarket Resources. For example, in response toDeveloping Medical Softwarecompanies will receive Cedars-Sinai Medical Center'sClinical Support, perform for itProduct Development Coaching and Testing. At the same time, startups can fully leverage Cedars-Sinai’s healthcare system, dedicating substantial time to shadowing physicians and observing clinical workflows to better understand user needs.

This is highly valuable and necessary for startups. Because in the medical field,Few companies fail due to technology; more often, the problem lies in entrepreneurs’ failure to identify the right needs or to provide solutions that truly address the issues. This stems from “cognitive bias” caused by entrepreneurs’ lack of access to real-world clinical scenarios.

Based on this point, propelled by Cedars-Sinai, the startup was able toIn hospital workflows and hardware facilitiesInteracting with healthcare professionals enables startups to gain a deeper understanding of their products within the healthcare system.Market Positioning, and rapidly test and continuously improve its products, thereby shortening the product validation process from two years to three months.

In the evaluation of startups, Cedars-Sinai in “Team Competency”aspects, as a strong team is often better equipped to address the various challenges startups face in their early stages.

Cedars-Sinai has always firmly believed that startups with strong management teams can drive any product or idea to success. Once a robust management team is identified, they seek out products they believe will have the greatest impact on the U.S. market and look for market traction, ensuring that innovative products deliver added value and help the team achieve its objectives.

Therefore, after conducting a comprehensive evaluation of startup teams’ expertise, technical capabilities, work methodologies, and prior experience to identify those that meet its criteria, Cedars-Sinai further assesses their technologies and products. It selects the products with the greatest market impact and potential, aligns the startups’ resource needs with the medical resources Cedars-Sinai can provide, and ensures that Cedars-Sinai can empower the selected companies to help them achieve their goals.

It is worth mentioning that Cedars-Sinai does not limit its collaborations to within its own hospital. “We aim to bring innovation to the healthcare system while providing growth opportunities for selected companies, enabling them to expand beyond Cedars-Sinai.,” said Anne Wellington, General Manager of Cedars-Sinai.

Because the Cedars-Sinai Accelerator is tightly integrated with its medical resources, it provides healthcare innovation startups with much-needed support. As a result, each cohort attracts nearly 600 applicant startups, making it one of the most popular healthcare-focused startup accelerators in the United States.

By the end of 2019, Cedars-Sinai had conducted five phases of accelerated courses, with a total of147 StartupsParticipation, with a cumulative total of over$2 billioninvestment, including from tech giants such as Google and Amazon, with over 80% of startups remaining active and creating approximately 4,000 jobs.

The Cedars-Sinai Accelerator Program requires careful and meticulous planning during its implementation to better fulfill its original mission of driving innovative technological development for the company.

Specifically, the plan can be broadly divided intoThree Stages：

Phase 1:Assign the most suitable mentor to each startup based on its goals.Mentors are drawn from a team of more than 300 individuals, including insiders from Cedars-Sinai and industry experts. These mentors meet with startup teams on a weekly basis, leveraging their experience and professional networks to provide support. They offer feedback on products, help refine product design, and guide startups on how to better integrate their solutions into healthcare systems.

Phase II:Intensive product development and market positioning coaching.At this stage, the accelerator will provide startups with feedback on their business models, value propositions, and market fit, helping them understand their product’s market positioning, explore business models, and develop pricing and marketing strategies.

Phase III:Invite venture capital firms and investors to meet with startups for fundraising.On the final day of the program, all startups will present their products to investors, potential clients, mentors, and the media in a centralized pitch session.

During the training program, Cedars-Sinai Medical Center also provides startups with courses and workshops related to healthcare and entrepreneurship, inviting experts from diverse backgrounds to share their experiences.

In addition, Cedars-Sinai holds weekly meetings to bring together all startups participating in the same cohort, enabling them to share successful experiences, discuss challenges encountered, and provide mutual support. Due to the small size of each training cohort, every startup receives personalized support; the program team communicates with the companies on a weekly basis to ensure they obtain the necessary assistance.

Through systematic analysis, we have found that the development of accelerators in the United States generally presentsMulti-level Spatial Distribution, Diversified Investment Entities, Varied Investment Models, Accelerated Service Personalization, and Exceptional Economic PerformanceThese features clearly demonstrate the benefits of accelerator development, indicating that the emergence of accelerators is a significant tangible force driving corporate growth and economic progress.

Taking Cedars-Sinai as an example, it serves both as a provider of technical resources and as a product developer. To illustrate its logic with a vivid analogy, for startups in their early stages, an “accelerator” is similar to what is known as a “cheat code” or “hack” in gaming terminology. It provides capabilities beyond the material foundations that these companies inherently possess, enabling entrepreneurs who could not overcome challenges on their own to confront difficulties and risks that would otherwise be unbearable, thereby accelerating their “level completion.” However, it is important to note that while the two share functional similarities, they are fundamentally different in nature—one being positive and legitimate, the other negative and illicit.

Currently, the medical sector in China has established bases in multiple regions across the country, vigorously developing industrial incubators and accelerators. On November 17, 2021, the “Sequoia China Intelligent Healthcare Accelerator“Officially launched, its core mission is to support and accompany more AI-driven healthcare innovation enterprises in their growth within China, actively contributing to Shanghai’s efforts to build a world-class biomedical industry cluster.

In the face of the strong foundation established by foreign medical accelerators, China’s medical innovation accelerators must also demonstrate their capabilities by strengthening digitalization and intelligence, accumulating more technical, talent, and management resources, and formulating comprehensive strategies to meet the needs of startups. By helping entrepreneurs bring their innovative technological products to market, these accelerators can significantly improve the quality, efficiency, and care services of healthcare.